FindTrial
Sign In

Effect of topical application of magnesium 2% , althaea officinalis 5% and althea officinalis 5% plus magnesium 2% Cream containing compare with calendula cream in the treatment of Diaper Dermatitis in Children.

Evaluation effect of topical application of magnesium 2% , althaea officinalis 5% and althea officinalis 5% plus magnesium 2% Cream containing compare with calendula cream in the treatment of Diaper Dermatitis in Children.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016041710222N6
Enrollment
128
Registered
2016-05-29
Start date
2016-04-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diaper rash. Diaper [napkin] dermatitis

Interventions

Intervention 1: , first group used althaea officinalis 5% cream containing and the second group cream containing magnesium 2% and the third group combines althaea officinalis5% and magnesium 2% Crea
Treatment - Drugs
, first group used althaea officinalis 5% cream containing and the second group cream containing magnesium 2% and the third group combines althaea officinalis5% and magnesium 2% Cream 3 times a day
the control group used receive Calendula Cream 3 times a day after changing diaper topical use in place

Sponsors

Vice chancellor for research of Shahrekord University of Medical Scie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 2 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: diagnosis of diaper rash; children under 2 years. Exclusion Criteria: other diseases with diaper rash such as lupus.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Diaper rash symptom. Timepoint: Baseline and two weeks later. Method of measurement: observation.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbolfazl Khoshdel

Shahrekord University of Medical Sciences

keivaniz@yahoo.com+98 38 3222 0016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026